OncoPep Receives $2,525,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d8caf6d4-61c7-416b-89fa-af47c3073fde&Preview=1 -
Date
4/27/2012 -
Company Name
OncoPep -
Mailing Address
520 Boston Street North Andover, MA 01845 -
Company Description
OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The Company’s proprietary core technology was developed in the laboratory of Dr. Kenneth Anderson, M.D., a world leader in cancer treatment, at the Dana Farber Cancer Institute. -
Website
http://www.oncopep.com -
Transaction Type
Venture Equity -
Transaction Amount
$2,525,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
